AstraZeneca PLC AZN-GB:London Stock Exchange

RT Quote | Exchange | GBp

Last | 12/07/22 GMT

11,258.00UNCH (UNCH)

52 week range

8,090.32 - 11,540.00

Open0.00
Day High0.00
Day Low0.00
Prev Close11,258.00
52 Week High11,540.00
52 Week High Date08/25/22
52 Week Low8,090.32
52 Week Low Date12/07/21

Key Stats

Market Cap211,482.21M
Shares Out1,549.51M
10 Day Average Volume1.26M
Dividend221.70
Dividend Yield1.97%
Beta0.31
YTD % Change29.73

KEY STATS

Open0.00
Day High0.00
Day Low0.00
Prev Close11,258.00
52 Week High11,540.00
52 Week High Date08/25/22
52 Week Low8,090.32
52 Week Low Date12/07/21
Market Cap211,482.21M
Shares Out1,549.51M
10 Day Average Volume1.26M
Dividend221.70
Dividend Yield1.97%
Beta0.31
YTD % Change29.73

RATIOS/PROFITABILITY

EPS (TTM)117.93
P/E (TTM)95.46
Fwd P/E (NTM)-
EBITDA (TTM)-
ROE (TTM)-
Revenue (TTM)-
Gross Margin (TTM)-
Net Margin (TTM)-
Debt To Equity (MRQ)-

EVENTS

Earnings Date-
Ex Div Date08/11/2022
Div Amount76.40
Split Date-
Split Factor-

Latest On AstraZeneca PLC

Stocks making the biggest moves midday: Six Flags, Rivian, Bumble, CoinbaseNovember 10, 2022CNBC.com
Stocks making the biggest moves premarket: Tapestry, WeWork, Rivian and othersNovember 10, 2022CNBC.com
Options Action: A bet against AstraZenecaNovember 8, 2022CNBC.com

Content From Our Affiliates

There is no recent news for this security.

Profile

AstraZeneca PLC is a patient-focused pharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines. The Company is focused on various therapy areas, such as Oncology; BioPharmaceuticals (comprising Cardiovascular, Renal & Metabolism (CVRM) and Respiratory & Immunology (R&I)), and Rare Disease. Its pipeline forms a robust portfolio of investigational therapies in various stages of clinical development....

Michel Demare

Non-Executive Independent Chairman of the Board - Designate

Leif Johansson

Independent Non-Executive Chairman of the Board

Pascal Soriot

Chief Executive Officer, Executive Director

Aradhana Sarin M.D.

Chief Financial Officer, Executive Director

Ruud Dobber Ph.D.

Executive Vice President - BioPharmaceuticals Business Unit

Address

1 Francis Crick Avenue

Cambridge

CB2 0AA

United Kingdom

https://www.astrazeneca.com/Home